This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tread Carefully in Bank-Heavy U.K. Funds

The U.K. might be the most comfortable foreign country for U.S. investors.

But like the U.S., the U.K. has had to endure market cycles that investors should be wary of.

The current global slowdown started in the financial sector. The distorted yield curve warned well in advance that trouble was coming, and anyone heeding that warning has missed some of this pain.

The yield curve inverts every so often, and for my money, that signals trouble. When this occurs I want to reduce financial exposure, which requires looking under the hood of any broad-based products you own.

Consider iShares UK Index Fund (EWU).

EWU currently has a 23% weight to financials, down from 29%, according to my best estimate. U.K. banks have generally felt the same pain as those in the U.S., creating a big drag in the U.K. market. This is not unusual given that many markets have a large weighting in financials, a drawback for many country funds.

Given the heavy weighting in financials, EWU has become a less than ideal way for investors to access the U.K.

Just as in the U.S., staples and health care are often good places to overweight in a bear market decline. For example, see the chart below of EWU against GlaxoSmithkline (GSK - Get Report) (GSK).

Click here for larger image.

Despite a rough go for GSK in January, when the correlation was quite high, GSK has done what an investor might have hoped for over the course of the entire year, offering investors a good place to hide during the current downtrend.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
EWU $18.10 0.00%
GSK $41.95 0.00%
AAPL $126.00 0.00%
FB $87.55 0.00%
GOOG $522.86 0.00%

Markets

DOW 17,683.58 -46.53 -0.26%
S&P 500 2,068.76 -8.02 -0.39%
NASDAQ 4,991.94 -17.2740 -0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs